Abstract
Multiple ANRIL transcriptional isoforms, such as lncANRIL and circANRIL have been identified. We sought to explore their diagnostic value in patients with coronary artery disease (CAD). First, we selected six target ANRIL isoforms and measured their expression in CAD patients and controls in the peripheral blood. Their diagnostic values were evaluated. circANRIL(exon14-4) was identified as the best potential biomarker. Afterwards, we validated its diagnostic value and evaluated its prognostic value in a larger clinical cohort. Among six tested ANRILs, lncANRIL(exon1) and lncANRIL(exon4-6) in the CAD patients were significantly increased, while circANRIL(exon14-4) was downregulated. circANRIL(exon14-4) had the highest diagnostic value among the three isoforms. The combination of circANRIL(exon14-4) and other factors resulted in a more accurate differentiation of CAD patients. Moreover, lower expression of circANRIL(exon14-4) was associated with higher incidence of MACE. circANRIL(exon14-4) is closely associated with CAD risk and severity, which provides a promising circulating biomarker for CAD diagnosis and prognosis.
Similar content being viewed by others
Abbreviations
- ANRIL:
-
Antisense non-coding RNA in the INK4 locus
- lncANRIL:
-
Linear ANRIL
- circANRIL:
-
Circular ANRIL
- CAD:
-
Coronary artery disease
- ROC:
-
Receiver operating characteristic
- GS:
-
Gensini score
- DM:
-
Diabetes mellitus
- BMI:
-
Body mass index
- TC:
-
Total cholesterol
- TG:
-
Total triglycerides
- HDL-C:
-
High-density lipoprotein cholesterol
- LDL-C:
-
Low-density lipoprotein cholesterol
- Cr:
-
Creatinine
- hs-CRP:
-
Hypersensitive C-reactive protein
- GAPDH:
-
Glyceraldehyde 3-phosphate dehydrogenase
- AUC:
-
Area under the receiver operating characteristic curve
- OR:
-
Odds ratio
- VSMC:
-
Vascular smooth muscle cell
- MACE:
-
Major adverse cardiac events
- IQR:
-
Interquartile range
- HR:
-
Hazard ratio
References
Zhao, Z., Li, X., Gao, C., Jian, D., Hao, P., Rao, L., et al. (2017). Peripheral blood circular RNA hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery disease. Scientific Reports, 7, 39918. https://doi.org/10.1038/srep39918.
Mboi, N., Murty Surbakti, I., Trihandini, I., Elyazar, I., Houston Smith, K., Bahjuri Ali, P., et al. (2018). On the road to universal health care in Indonesia, 1990-2016: A systematic analysis for the global burden of disease study 2016. Lancet, 392(10147), 581–591. https://doi.org/10.1016/S0140-6736(18)30595-6.
Hitchner, E., Zayed, M., Varu, V., Lee, G., Aalami, O., & Zhou, W. (2015). A prospective evaluation of using IVUS during percutaneous superficial femoral artery interventions. Annals of Vascular Surgery, 29(1), 28–33. https://doi.org/10.1016/j.avsg.2014.07.026.
Xuan, T. M., Wang, X. X., Pu, X. Y., Han, W. L., & Guo, X. G. (2020). Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: A case report. Journal of Zhejiang University. Science. B, 21(5), 411–415. https://doi.org/10.1631/jzus.B2000182.
Pasmant, E., Sabbagh, A., Vidaud, M., & Bieche, I. (2011). ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. The FASEB Journal, 25(2), 444–448. https://doi.org/10.1096/fj.10-172452.
Schaefer, A. S., Richter, G. M., Groessner-Schreiber, B., Noack, B., Nothnagel, M., El Mokhtari, N. E., et al. (2009). Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genetics, 5(2), e1000378. https://doi.org/10.1371/journal.pgen.1000378.
Bochenek, G., Hasler, R., El Mokhtari, N. E., Konig, I. R., Loos, B. G., Jepsen, S., et al. (2013). The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10. Human Molecular Genetics, 22(22), 4516–4527. https://doi.org/10.1093/hmg/ddt299.
Cho, H., Shen, G. Q., Wang, X., Wang, F., Archacki, S., Li, Y., et al. (2019). Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes. The Journal of Biological Chemistry, 294(11), 3881–3898. https://doi.org/10.1074/jbc.RA118.005050.
Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M., et al. (2011). Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene, 30(16), 1956–1962. https://doi.org/10.1038/onc.2010.568.
Li, Z., Huang, C., Bao, C., Chen, L., Lin, M., Wang, X., et al. (2015). Exon-intron circular RNAs regulate transcription in the nucleus. Nature Structural & Molecular Biology, 22(3), 256–264. https://doi.org/10.1038/nsmb.2959.
Li, P., Chen, S., Chen, H., Mo, X., Li, T., Shao, Y., et al. (2015). Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clinica Chimica Acta, 444, 132–136. https://doi.org/10.1016/j.cca.2015.02.018.
Palazzo, A. F., & Lee, E. S. (2015). Non-coding RNA: What is functional and what is junk? Frontiers in Genetics, 6, 2. https://doi.org/10.3389/fgene.2015.00002.
Yari, M., Bitarafan, S., Broumand, M. A., Fazeli, Z., Rahimi, M., Ghaderian, S. M. H., et al. (2018). Association between long noncoding RNA ANRIL expression variants and susceptibility to coronary artery disease. International Journal of Molecular and Celullar Medicine, 7(1), 1–7. https://doi.org/10.22088/IJMCM.BUMS.7.1.1.
Holdt, L. M., Beutner, F., Scholz, M., Gielen, S., Gabel, G., Bergert, H., et al. (2010). ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(3), 620–627. https://doi.org/10.1161/ATVBAHA.109.196832.
Gensini, G. G. (1983). A more meaningful scoring system for determining the severity of coronary heart disease. The American Journal of Cardiology, 51(3), 606. https://doi.org/10.1016/s0002-9149(83)80105-2.
Sinning, C., Lillpopp, L., Appelbaum, S., Ojeda, F., Zeller, T., Schnabel, R., et al. (2013). Angiographic score assessment improves cardiovascular risk prediction: The clinical value of SYNTAX and Gensini application. Clinical Research in Cardiology, 102(7), 495–503. https://doi.org/10.1007/s00392-013-0555-4.
Huang, M., Zhong, Z., Lv, M., Shu, J., Tian, Q., & Chen, J. (2016). Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma. Oncotarget, 7(30), 47186–47200. https://doi.org/10.18632/oncotarget.9706.
Aarabi, G., Zeller, T., Heydecke, G., Munz, M., Schafer, A., & Seedorf, U. (2018). Roles of the Chr.9p21.3 ANRIL locus in regulating inflammation and implications for anti-inflammatory drug target identification. Frontiers in Cardiovascular Medicine, 5, 47. https://doi.org/10.3389/fcvm.2018.00047.
Qin, M., Liu, G., Huo, X., Tao, X., Sun, X., Ge, Z., et al. (2016). Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomarkers, 16(1), 161–169. https://doi.org/10.3233/CBM-150552.
Gutowska, K., Formanowicz, D., & Formanowicz, P. (2017). The effect of cigarette smoking on endothelial damage and atherosclerosis development - Modeled and analyzed using Petri nets. Archives of Control Sciences, 27. https://doi.org/10.1515/acsc-2017-0013.
Yang, Y., Cai, Y., Wu, G., Chen, X., Liu, Y., Wang, X., et al. (2015). Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clinical Science (London, England), 129(8), 675–685. https://doi.org/10.1042/CS20150121.
Shan, K., Jiang, Q., Wang, X. Q., Wang, Y. N., Yang, H., Yao, M. D., et al. (2016). Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell Death & Disease, 7(6), e2248. https://doi.org/10.1038/cddis.2016.145.
Rahimi, E., Ahmadi, A., Boroumand, M. A., Mohammad Soltani, B., & Behmanesh, M. (2018). Association of ANRIL expression with coronary artery disease in type 2 diabetic patients. Cell Journal, 20(1), 41–45. https://doi.org/10.22074/cellj.2018.4821.
Hu, Y., & Hu, J. (2019). Diagnostic value of circulating lncRNA ANRIL and its correlation with coronary artery disease parameters. Brazilian Journal of Medical and Biological Research, 52(8), e8309. https://doi.org/10.1590/1414-431X20198309.
Liu, Z. F., Hu, W. W., Li, R., Gao, Y., Yan, L. L., & Su, N. (2020). Expression of lncRNA-ANRIL in patients with coronary heart disease before and after treatment and its short-term prognosis predictive value. European Review for Medical and Pharmacological Sciences, 24(1), 376–384. https://doi.org/10.26355/eurrev_202001_19936.
Nawaz, S. K., Noreen, A., Rani, A., Yousaf, M., & Arshad, M. (2015). Association of the rs10757274 SNP with coronary artery disease in a small group of a Pakistani population. Anatolian Journal of Cardiology, 15(9), 709–715. https://doi.org/10.5152/akd.2014.5470.
Chi, J. S., Li, J. Z., Jia, J. J., Zhang, T., Liu, X. M., & Yi, L. (2017). Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis. Journal of Huazhong University of Science and Technology. Medical Sciences, 37(6), 816–822. https://doi.org/10.1007/s11596-017-1812-y.
Lai, F., Orom, U. A., Cesaroni, M., Beringer, M., Taatjes, D. J., Blobel, G. A., et al. (2013). Activating RNAs associate with mediator to enhance chromatin architecture and transcription. Nature, 494(7438), 497–501. https://doi.org/10.1038/nature11884.
Cheng, J., Cai, M. Y., Chen, Y. N., Li, Z. C., Tang, S. S., Yang, X. L., et al. (2017). Variants in ANRIL gene correlated with its expression contribute to myocardial infarction risk. Oncotarget, 8(8), 12607–12619. https://doi.org/10.18632/oncotarget.14721.
Holdt, L. M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K., et al. (2013). Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genetics, 9(7), e1003588. https://doi.org/10.1371/journal.pgen.1003588.
Ashwal-Fluss, R., Meyer, M., Pamudurti, N. R., Ivanov, A., Bartok, O., Hanan, M., et al. (2014). circRNA biogenesis competes with pre-mRNA splicing. Molecular Cell, 56(1), 55–66. https://doi.org/10.1016/j.molcel.2014.08.019.
Holdt, L. M., Stahringer, A., Sass, K., Pichler, G., Kulak, N. A., Wilfert, W., et al. (2016). Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nature Communications, 7, 12429. https://doi.org/10.1038/ncomms12429.
Wang, L., Shen, C., Wang, Y., Zou, T., Zhu, H., Lu, X., et al. (2019). Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease. Atherosclerosis, 286, 88–96. https://doi.org/10.1016/j.atherosclerosis.2019.05.006.
Teeuw, W. J., Laine, M. L., Bizzarro, S., & Loos, B. G. (2015). A Lead ANRIL polymorphism is associated with elevated CRP levels in periodontitis: A pilot case-control study. PLoS One, 10(9), e0137335. https://doi.org/10.1371/journal.pone.0137335.
Zhang, X. O., Wang, H. B., Zhang, Y., Lu, X., Chen, L. L., & Yang, L. (2014). Complementary sequence-mediated exon circularization. Cell, 159(1), 134–147. https://doi.org/10.1016/j.cell.2014.09.001.
Funding
This research was supported by the Program of National Natural Science Foundation of China (No. 81470370); the Key Projects of Zhejiang Medical and Health Science and Technology Plan (Provincial and Ministerial Co-construction) (No. WKJ-ZJ-1819); and the Fundamental Research Funds for the Zhejiang Province Universities (No. 2019XZZX003-15).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethics Statement
This study was approved by the Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University (ethics approval No. IIT20200141A) and complied with the ethical principles of the Declaration of Helsinki of 1975, as revised in 2000.
Informed Consent Statement
Informed consent was obtained from all patients for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Additional information
Associate Editor Junjie Xiao oversaw the review of this article
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fang, J., Pan, Z., Wang, D. et al. Multiple Non-coding ANRIL Transcripts Are Associated with Risk of Coronary Artery Disease: a Promising Circulating Biomarker. J. of Cardiovasc. Trans. Res. 14, 229–237 (2021). https://doi.org/10.1007/s12265-020-10053-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-020-10053-0